Gemzar and Ipf - a phase IV clinical study of FDA data
Summary:
Ipf is reported as a side effect among people who take Gemzar (gemcitabine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Aredia, and have Metastases to bone.
The phase IV clinical study analyzes which people have Ipf when taking Gemzar. It is created by eHealthMe based on reports of 20,184 people who have side effects when taking Gemzar from the FDA, and is updated regularly.
What is Gemzar?
Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.
What is Ipf?
Ipf is found to be associated with 1,872 drugs and 2,253 conditions by eHealthMe. Check the latest studies of Ipf.
20,184 people reported to have side effects when taking Gemzar.
Among them, 202 people (1.0%) have Ipf.
Among these 202 people:
How long have people been on Gemzar when they have Ipf? *
What is the gender of people who have Ipf when taking Gemzar? *
What is the age of people who have Ipf when taking Gemzar? *
What are other drugs people take besides Gemzar? *
What are other side effects people have besides Ipf? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Gemzar and have Ipf?
- Check whether Ipf is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Gemzar:
- Gemzar (20,315 reports)
Ipf treatments and more:
- Ipf (79,192 reports)
How severe was Ipf and when was it recovered:
Expand to all the drugs that have ingredients of gemcitabine hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Common Gemzar side effects:
- Gemzar side effect: Malignant neoplasm progression (cancer tumour came back) (1,507 reports)
- Gemzar side effect: Anaemia (lack of blood) (1,415 reports)
- Gemzar side effect: Nausea (feeling of having an urge to vomit) (1,344 reports)
- Gemzar side effect: Dyspnea (difficult or laboured breathing) (1,175 reports)
- Gemzar side effect: Pneumonia (1,159 reports)
Browse all side effects of Gemzar:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon drugs associated with Ipf:
- Methotrexate side effect: Ipf (4,714 reports)
- Prednisone side effect: Ipf (4,117 reports)
- Humira side effect: Ipf (2,869 reports)
- Enbrel side effect: Ipf (2,842 reports)
- Ofev side effect: Ipf (2,063 reports)
- Remicade side effect: Ipf (2,043 reports)
- Actemra side effect: Ipf (2,024 reports)
- Leflunomide side effect: Ipf (1,957 reports)
- Xeljanz side effect: Ipf (1,940 reports)
- Pantoprazole side effect: Ipf (1,758 reports)
Browse all the drugs that are associated with Ipf:
- Ipf (1,868 drugs)
Common conditions associated with Ipf:
- Ra: 5,843 reports
- Ipf: 2,256 reports
- Atrial fibrillation/flutter: 1,089 reports
- Hypertension aggravated: 1,023 reports
- Blood pressure increased: 1,015 reports
- Psoriatic arthropathy: 851 reports
- Idiopathic pulmonary fibrosis: 843 reports
- Primary pulmonary hypertension: 793 reports
- Psoriasis: 789 reports
- Osteoporosis: 682 reports
Browse all the conditions that are associated with Ipf:
- Ipf (2,253 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on gemcitabine hydrochloride (the active ingredients of Gemzar) and Gemzar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Depression and Dry Mouth - now
- Could Zovirax cause Sinus Disorder? - a second ago
- Could Hydrodiuril cause Idiopathic Pulmonary Fibrosis? - 4 seconds ago
- Drug interactions of Viibryd and Krill - 6 seconds ago
- Primary Myelofibrosis and Skin Papilloma - 31 seconds ago
- Drug interactions of Fish Oil and Travatan - 35 seconds ago
- Drug interactions of Aripiprazole and Vortioxetine - 40 seconds ago
- Drug interactions of Amerge and Relpax - 45 seconds ago
- Drug interactions of Lescol Xl and Diazepam - 48 seconds ago
- Drug interactions of Diltiazem Hydrochloride and Tudorza Pressair - a minute ago